Skip to main content

Together we are beating cancer

Donate now

Treatment

Showing 12 out of 1220 results
A computer generated image showing two DNA helices in shades of blue.
  • Science & Technology
  • Health & Medicine

New test predicts how cancers will respond to chemotherapy

A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients. A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients.

by Amal Iman | News | 7 August 2025

7 August 2025

A computer graphic showing three researchers working in a lab. Above them are three white bubbles howing the bacteria in the gut microbiome, a 'drug made from a bug' and cancer cells being targeted by immune cells.

By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'. By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'.

by Helen Renshaw | Analysis | 22 July 2025

22 July 2025

An image of a radiotherapy machine. Its lights are glowing blue.

Our PLATO-ACT4 clinical trial has found a kinder and more targeted way of using radiotherapy to treat early-stage anal cancer. Our PLATO-ACT4 clinical trial has found a kinder and more targeted way of using radiotherapy to treat early-stage anal cancer.

by Amal Iman | News | 1 July 2025

1 July 2025

This entry is part 5 of 5 in the series Stand Up To Cancer
This entry is part 29 of 30 in the series That Cancer Conversation
A breast cancer cell seen through an electron microscope.

Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery

by Amal Iman, Tim Gunn | News | 13 May 2025

13 May 2025

A photo of Michelle Mitchell, Wes Streeting and Deborah's family members at the Crick

Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority

by Michelle Mitchell | Opinion | 23 April 2025

23 April 2025

A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025

This entry is part 24 of 30 in the series That Cancer Conversation
Microscope image of human colon cancer cells
  • Science & Technology
  • Health & Medicine

Bowel cancer awareness month: Common questions answered

To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer. To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer.

by Amy Warnock | In depth | 1 April 2025

1 April 2025

Researchers discussing work in lab

Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.

by Fiona Scott | News | 31 March 2025

31 March 2025

This entry is part 23 of 30 in the series That Cancer Conversation